What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
Sickle cell anemia, Internal medicine, Pediatrics, Stroke and Anemia are his primary areas of study.
His Sickle cell anemia research integrates issues from Cerebral infarction, Hemolytic anemia, Hemoglobinopathy, El Niño and Asthma.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Surgery and Cardiology.
His Pediatrics research incorporates elements of Physical therapy, Affect, Cohort study and Prospective cohort study.
Michael R. DeBaun has researched Stroke in several fields, including Epidemiology and Intensive care medicine.
Michael R. DeBaun combines subjects such as Cross-sectional study, Randomized controlled trial, Disease, Blood transfusion and Cohort with his study of Anemia.
His most cited work include:
- Association of In Vitro Fertilization with Beckwith-Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19 (773 citations)
- Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry (348 citations)
- Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulin-like growth factor II imprinting (323 citations)
What are the main themes of his work throughout his whole career to date?
Michael R. DeBaun spends much of his time researching Disease, Pediatrics, Sickle cell anemia, Internal medicine and Anemia.
His Disease study integrates concerns from other disciplines, such as Cell, Clinical trial, Cognition, Family medicine and Intensive care medicine.
The various areas that Michael R. DeBaun examines in his Pediatrics study include Incidence, Cohort study, Retrospective cohort study, Asthma and Prospective cohort study.
His work in Sickle cell anemia addresses issues such as Stroke, which are connected to fields such as Blood transfusion and Randomized controlled trial.
His study looks at the intersection of Internal medicine and topics like Surgery with Beckwith–Wiedemann syndrome.
His study in Beckwith–Wiedemann syndrome is interdisciplinary in nature, drawing from both Wilms' tumor and Genomic imprinting.
He most often published in these fields:
- Disease (38.78%)
- Pediatrics (36.83%)
- Sickle cell anemia (36.83%)
What were the highlights of his more recent work (between 2018-2021)?
- Disease (38.78%)
- Sickle cell anemia (36.83%)
- Internal medicine (35.12%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Disease, Sickle cell anemia, Internal medicine, Pediatrics and Anemia.
His Disease study combines topics from a wide range of disciplines, such as Cell, Clinical trial, Family medicine, Intensive care medicine and Obstetrics.
His Sickle cell anemia research is multidisciplinary, relying on both Priapism, Genetic disorder, Cognition, Transcranial Doppler and Stroke prevention.
His Internal medicine research integrates issues from Gastroenterology and Cardiology.
The Pediatrics study combines topics in areas such as Stroke, Primary prevention, Body mass index and Health services research.
His Anemia research is multidisciplinary, relying on both Heterozygote advantage, Ultrasonography, Cohort and MEDLINE.
Between 2018 and 2021, his most popular works were:
- Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. (95 citations)
- Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative. (52 citations)
- Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis (25 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary areas of study are Disease, Pediatrics, Anemia, Sickle cell anemia and Cell.
Michael R. DeBaun has included themes like Clinical trial, MEDLINE, Quality of life, Intensive care medicine and Cohort in his Disease study.
Michael R. DeBaun has researched Pediatrics in several fields, including Stroke, Mentorship, Debriefing and Health policy.
His Anemia research incorporates elements of Homologous chromosome, Blood transfusion and Bioinformatics.
His Sickle cell anemia study is associated with Internal medicine.
His Cell research includes elements of Cerebral hemodynamics, Fixed dose, Primary prevention, Pathology and Bone marrow transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
